NCT05918081 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Mancha-Triguero D, Garcia-Rubio J, Antunez A, Ibanez SJ
Physical and Physiological Profiles of Aerobic and Anaerobic Capacities in Young Basketball Players. Int J Environ Res Public Health. 2020 Feb 21;17(4):1409. doi: 10.3390/ijerph17041409.
McInnes SE, Carlson JS, Jones CJ, McKenna MJ
The physiological load imposed on basketball players during competition. J Sports Sci. 1995 Oct;13(5):387-97. doi: 10.1080/02640419508732254.

The Relationship of Aerobic Capacity With Agility, Core Muscle Endurance and Peripheral Muscle Strength in Adolescent Basketball Players

Clinical trial NCT05918081 - References